ABSTRACT
The management of pregnant patients with essential thrombocythemia (ET) and polycythemia vera (PV) may be problematic. In the literature there are ~300 cases of pregnancies reported in ET and less than 50 pregnancies reported in PV. To reduce the effect of reporting bias, we selected articles with either > 10 pregnancies or at least six patients, and here report on the outcome of 195 pregnancies in ET and 36 pregnancies in PV patients. The live birth rate was ~60% in ET and 58% in PV. Spontaneous abortion during the first trimester was the most frequent fetal complication, occurring in 31% of ET pregnancies and in 22% of PV pregnancies, respectively. Major maternal complications were more frequent in PV compared with ET (44.4 versus 7.7%). Treatment with low-dose aspirin during pregnancy in ET seemed to reduce complications and also seemed beneficial during pregnancy in PV. In high-risk pregnancies, the additional use of low molecular weight heparin and/or interferon α should be considered. This article also describes a registry for an observational study concerning pregnancy in chronic Philadelphia chromosome-negative myeloproliferative disorders within the European LeukemiaNet. A potential management algorithm for pregnancies in ET or PV is also provided.
KEYWORDS
Essential thrombocythemia - polycythemia vera - pregnancy - observational study - European LeukemiaNet
REFERENCES
-
1
McNally R J, Roman E, Cartwright R A.
Leukemias and lymphomas: time trends in the UK, 1984-93.
Cancer Causes Control.
1999;
10(1)
35-42
-
2
Finazzi G, Harrison C.
Essential thrombocythemia.
Semin Hematol.
2005;
42(4)
230-238
-
3
Bates S M, Ginsberg J S.
Thrombosis in pregnancy.
Curr Opin Hematol.
1997;
4(5)
335-343
-
4
Bangerter M, Guthner C, Beneke H, Hildebrand A, Grunewald M, Griesshammer M.
Pregnancy in essential thrombocythaemia: treatment and outcome of 17 pregnancies.
Eur J Haematol.
2000;
65(3)
165-169
-
5
Beard J, Hillmen P, Anderson C C, Lewis S M, Pearson T C.
Primary thrombocythaemia in pregnancy.
Br J Haematol.
1991;
77(3)
371-374
-
6
Beressi A H, Tefferi A, Silverstein M N, Petitt R M, Hoagland H C.
Outcome analysis of 34 pregnancies in women with essential thrombocythemia.
Arch Intern Med.
1995;
155(11)
1217-1222
-
7
Griesshammer M, Grunewald M, Michiels J J.
Acquired thrombophilia in pregnancy: essential thrombocythemia.
Semin Thromb Hemost.
2003;
29(2)
205-212
-
8
Griesshammer M, Heimpel H, Pearson T C.
Essential thrombocythemia and pregnancy.
Leuk Lymphoma.
1996;
22(suppl 1)
57-63
-
9
Harrison C.
Pregnancy and its management in the Philadelphia negative myeloproliferative diseases.
Br J Haematol.
2005;
129(3)
293-306
-
10
Niittyvuopio R, Juvonen E, Kaaja R et al..
Pregnancy in essential thrombocythaemia: experience with 40 pregnancies.
Eur J Haematol.
2004;
73(6)
431-436
-
11
Robinson S, Bewley S, Hunt B J, Radia D H, Harrison C N.
The management and outcome of 18 pregnancies in women with polycythemia vera.
Haematologica.
2005;
90(11)
1477-1483
-
12
Taylor U B, Bardeguez A D, Iglesias N, Gascon P.
Idiopathic myelofibrosis in pregnancy: a case report and review of the literature.
Am J Obstet Gynecol.
1992;
167(1)
38-39
-
13
Gotic M, Cvetkovic M, Bozanovic T, Cemerikic V.
Successful treatment of primary myelofibrosis with thrombocytosis during pregnancy with alfa-interferon.
Srp Arh Celok Lek.
2001;
129(11-12)
304-308
-
14
Hoagland H C, Silverstein M N.
Primary thrombocythemia in the young patient.
Mayo Clin Proc.
1978;
53(9)
578-580
-
15
Pagliaro P, Arrigoni L, Muggiasca M L, Poggio M, Russo U, Rossi E.
Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases.
Am J Hematol.
1996;
53(1)
6-10
-
16
Vantroyen B, Vanstraelen D.
Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature.
Acta Haematol.
2002;
107(3)
158-169
-
17
Wright C A, Tefferi A.
A single institutional experience with 43 pregnancies in essential thrombocythemia.
Eur J Haematol.
2001;
66(3)
152-159
-
18
Zahner J, Wehmeier A, Schneider W.
Pregnancy in essential thrombocythemia. Manifestation time and risk for mother and child [In German].
Dtsch Med Wochenschr.
1995;
120(44)
1517-1523
-
19
Bellucci S, Janvier M, Tobelem G et al..
Essential thrombocythemias. Clinical evolutionary and biological data.
Cancer.
1986;
58(11)
2440-2447
-
20
Leone G, De Stefano V, D'Addosio A.
Essential thrombocythemia: pregnancy.
Haematologica.
1991;
76(suppl 3)
365-367
-
21
Randi M L, Rossi C, Fabris F, Girolami A.
Essential thrombocythemia in young adults: treatment and outcome of 16 pregnancies.
J Intern Med.
1999;
246(5)
517-518
-
22
Cairns J W, Mahon A, Waters D A, Chanarin I.
Platelet levels in pregnancy.
J Clin Pathol.
1977;
30(4)
392
-
23
Sejeny S A, Eastham R D, Baker S R.
Platelet counts during normal pregnancy.
J Clin Pathol.
1975;
28(10)
812-813
-
24
Chow E Y, Haley L P, Vickars L M.
Essential thrombocythemia in pregnancy: platelet count and pregnancy outcome.
Am J Hematol.
1992;
41(4)
249-251
-
25
Cincotta R, Higgins J R, Tippett C et al..
Management of essential thrombocythaemia during pregnancy.
Aust NZ J Obstet Gynaecol.
2000;
40(1)
33-37
-
26
Randi M L, Rossi C, Fabris F, Girolami A.
Essential thrombocythemia in young adults: major thrombotic complications and complications during pregnancy-a follow-up study in 68 patients.
Clin Appl Thromb Hemost.
2000;
6(1)
31-35
-
27
Hunt B J, Doughty H A, Majumdar G et al..
Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies.
Thromb Haemost.
1997;
77(1)
39-43
-
28
Hunt B J, Gattens M, Khamashta M, Nelson-Piercy C, Almeida A.
Thromboprophylaxis with unmonitored intermediate-dose low molecular weight heparin in pregnancies with a previous arterial or venous thrombotic event.
Blood Coagul Fibrinolysis.
2003;
14(8)
735-739
-
29
Gris J C, Mercier E, Quere I et al..
Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder.
Blood.
2004;
103(10)
3695-3699
-
30
Sanson B J, Lensing A W, Prins M H et al..
Safety of low-molecular-weight heparin in pregnancy: a systematic review.
Thromb Haemost.
1999;
81(5)
668-672
-
31
Petit J J, Callis M, Fernandez de Sevilla A.
Normal pregnancy in a patient with essential thrombocythemia treated with interferon-alpha 2b.
Am J Hematol.
1992;
40(1)
80
-
32
Thornley S, Manoharan A.
Successful treatment of essential thrombocythemia with alpha interferon during pregnancy.
Eur J Haematol.
1994;
52(1)
63-64
-
33
Williams J M, Schlesinger P E, Gray A G.
Successful treatment of essential thrombocythaemia and recurrent abortion with alpha interferon.
Br J Haematol.
1994;
88(3)
647-648
-
34
Pulik M, Lionnet F, Genet P, Petitdidier C, Jary L.
Platelet counts during pregnancy in essential thrombocythaemia treated with recombinant alpha-interferon.
Br J Haematol.
1996;
93(2)
495
-
35
Shpilberg O, Shimon I, Sofer O, Dolitski M, Ben-Bassat I.
Transient normal platelet counts and decreased requirement for interferon during pregnancy in essential thrombocythaemia.
Br J Haematol.
1996;
92(2)
491-493
-
36
Schmidt H H, Neumeister P, Kainer F, Karpf E F, Linkesch W, Sill H.
Treatment of essential thrombocythemia during pregnancy: antiabortive effect of interferon-alpha?.
Ann Hematol.
1998;
77(6)
291-292
-
37
Kumar A R, Hale T W, Mock R E.
Transfer of interferon alfa into human breast milk.
J Hum Lact.
2000;
16(3)
226-228
-
38
Doll D C, Ringenberg Q S, Yarbro J W.
Antineoplastic agents and pregnancy.
Semin Oncol.
1989;
16(5)
337-346
-
39
Falconer J, Pineo G, Blahey W, Bowen T, Docksteader B, Jadusingh I.
Essential thrombocythemia associated with recurrent abortions and fetal growth retardation.
Am J Hematol.
1987;
25(3)
345-347
-
40
Mercer B, Drouin J, Jolly E, d'Anjou G.
Primary thrombocythemia in pregnancy: a report of two cases.
Am J Obstet Gynecol.
1988;
159(1)
127-128
-
41
Koh L P, Devendra K, Tien S L.
Four pregnancies in two patients with essential thrombocythaemia-a case report.
Ann Acad Med Singapore.
2002;
31(3)
353-356
-
42
Horlocker T T, Wedel D J.
Spinal and epidural blockade and perioperative low molecular weight heparin: smooth sailing on the Titanic.
Anesth Analg.
1998;
86(6)
1153-1156
-
43
Checketts M R, Wildsmith J A.
Central nerve block and thromboprophylaxis-is there a problem?.
Br J Anaesth.
1999;
82(2)
164-167
-
44
Willoughby S J, Fairhead S, Woodcock B E, Pearson T C.
Postpartum thrombosis in primary thrombocythaemia.
Eur J Haematol.
1997;
59(2)
121-123
-
45
Michiels J J.
Essential thrombocythemia is not associated with postpartum thrombosis or increased risk of venous thrombosis.
Eur J Haematol.
1998;
60
138-139
Professor
M GriesshammerM.D. Ph.D.
Department of Medicine III, Medizinische Universitätsklinik
Robert-Koch-Strasse 8, D-89081 Ulm, Germany
Email: martin.griesshammer@medizin.uni-ulm.de
